ITB vs XBI
iShares US Home Construction ETF vs SPDR S&P Biotech ETF
ITB—
iShares US Home Construction ETF
US homebuilding and construction companies.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | ITB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | State Street |
ITB top holdings
Holdings data unavailable for ITB.
XBI top holdings
Holdings data unavailable for XBI.
About ITB
ITB (iShares US Home Construction ETF) is US homebuilding and construction companies.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.